Defunct Company
Total Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
5,914
NCT00391417
Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 30, 2003
Completion: Apr 30, 2005
NCT00613002
Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Start: Dec 31, 2006
Completion: Sep 30, 2011
NCT00612742
Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
Start: Jan 31, 2008
Completion: Dec 31, 2012
NCT00657501
Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Start: Mar 31, 2008
NCT01235754
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Start: Oct 31, 2010
Completion: Jan 31, 2012
NCT01696877
A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer
Phase: Phase 1/2
Role: Collaborator
Start: Jan 18, 2013
Completion: Dec 18, 2018